Introduction
Unexpected Pneumocystis carinii pneumonia (PCP) led to the identification of the acquired immunodeficiency syndrome (AIDS). The laboratory diagnosis of P carinii infection has had a less auspicious start. As this fungus is not easily grown, there has been a tendency for physicians to make a clinical diagnosis. Early and rapid confirmation of the diagnosis of PCP is important and the development of sensitive and specific tests has made such evaluation possible.1 This paper will critically examine the different types of specimen and the laboratory techniques used for the identification of P carinii. The role of serology will be discussed.
The fact that the vast majority of AIDS patients develop PCP during their illness2 has been a great stimulus to research into PCP. Yet, it must be remembered that PCP is also a major problem for other immunocompromised patients in whom the pathology may be different, and other laboratory tests such as serology may be more relevant. 34 Consequently diagnosis of P carinii infection in AIDS and non-AIDS patients will be considered. In the future newer laboratory techniques may increase the sensitivity of diagnosis. Recently the polymerase chain reaction has been applied to the diagnosis of PCP with considerable success. 5 However, all of the laboratory techniques, both new and old, have advantages and disadvantages. In addition, the use of prophylaxis and greater awareness of PCP by clinicians will result in earlier diagnosis, and the role of laboratory tests in this changing environment needs careful assessment. This paper attempts to identify a rational approach to the investigation of P carinii infection in terms of the types of specimens and tests. Biopsy can also be performed transthoracically by percutaneous needle aspiration. Diagnostic yields of more than 80% have been reported, but may be associated with significant morbidity. In a series of 27 cancer patients there was a 30% incidence of complications: eight pneumothorax, one massive haemothorax and two deaths directly related to the Investigation of PCP The best approach to the investigation of PCP depends on many factors. The degree of immunocompromise, the severity of illness in the patient, the expertise in obtaining noninvasive specimens, the availability of invasive procedures, and the expertise of the laboratory are critical considerations. However, one of the most significant factors in reducing the mortality of PCP in the last 5 years has been increased medical and patient awareness of the condition,40 leading to earlier diagnosis and treatment. A scheme for the investigation of patients with suspected PCP is depicted in the figure.
Although the clinical presentation of PCP is not diagnostic, the condition should be suspected in individuals with immunocompromise who are short of breath, have a fever and a dry cough (fig) . Part of the difficulty in diagnosis is the spectrum of clinical findings: fever is present in about 90% of cases, breathlessness in 80% and a dry cough in 50%.2À mong HIV infected individuals, illness may be insidious and respiratory failure may occur in patients presenting later or among children. Increasingly, PCP will be found in HIV infected individuals, and the infection should be considered in patients at high risk of HIV. 
